129 related articles for article (PubMed ID: 36331847)
1. Risk of skin cancer in kidney, liver and heart recipients: A nationwide population-based study in Taiwan.
Liu SW; Wang WM; Chiang CP; Chung CH; Tsao CH; Chien WC; Hung CT
Indian J Dermatol Venereol Leprol; 2023; 89(3):372-377. PubMed ID: 36331847
[TBL] [Abstract][Full Text] [Related]
2. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan.
Yeh CC; Khan A; Muo CH; Yang HR; Li PC; Chang CH; Chen TL; Jeng LB; Liao CC
Exp Clin Transplant; 2020 Apr; 18(2):224-233. PubMed ID: 32133940
[TBL] [Abstract][Full Text] [Related]
3. Cancer Incidence among Heart, Kidney, and Liver Transplant Recipients in Taiwan.
Lee KF; Tsai YT; Lin CY; Hsieh CB; Wu ST; Ke HY; Lin YC; Lin FY; Lee WH; Tsai CS
PLoS One; 2016; 11(5):e0155602. PubMed ID: 27196400
[TBL] [Abstract][Full Text] [Related]
4. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens.
Jensen P; Hansen S; Møller B; Leivestad T; Pfeffer P; Geiran O; Fauchald P; Simonsen S
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):177-86. PubMed ID: 10025742
[TBL] [Abstract][Full Text] [Related]
5. Risk of Secondary Malignancies in Hematopoietic Stem Cell Transplantation Recipients: A Nationwide Population-Based Study in Taiwan.
Liu HL; Chen YH; Chung CH; Wu GJ; Tsao CH; Sun CA; Chien WC; Hung CT
Balkan Med J; 2023 Mar; 40(2):131-138. PubMed ID: 36804217
[TBL] [Abstract][Full Text] [Related]
6. The impact of switching to mTOR inhibitor-based immunosuppression on long-term non-melanoma skin cancer incidence and renal function in kidney and liver transplant recipients.
Murray SL; Daly FE; O'Kelly P; O'Leary E; Deady S; O'Neill JP; Dudley A; Rutledge NR; McCormick A; Houlihan DD; Williams Y; Morris PG; Ni Raghallaigh S; Moloney FJ; Sexton DJ; Conlon PJ
Ren Fail; 2020 Nov; 42(1):607-612. PubMed ID: 32605413
[No Abstract] [Full Text] [Related]
7. Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study).
Stenz NA; Stampf S; Arnold AW; Cozzio A; Dickenmann M; Gaide O; Harms M; Hunger RE; Laffitte E; Mühlstädt M; Nägeli M; Hofbauer GFL;
Dermatology; 2021; 237(6):970-980. PubMed ID: 33227788
[TBL] [Abstract][Full Text] [Related]
8. Association of HLA Antigen Mismatch With Risk of Developing Skin Cancer After Solid-Organ Transplant.
Gao Y; Twigg AR; Hirose R; Roll GR; Nowacki AS; Maytin EV; Vidimos AT; Rajalingam R; Arron ST
JAMA Dermatol; 2019 Mar; 155(3):307-314. PubMed ID: 30673077
[TBL] [Abstract][Full Text] [Related]
9. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
10. Melanoma incidence, stage, and survival after solid organ transplant: A population-based cohort study in Ontario, Canada.
Park CK; Dahlke EJ; Fung K; Kitchen J; Austin PC; Rochon PA; Chan AW
J Am Acad Dermatol; 2020 Sep; 83(3):754-761. PubMed ID: 32111554
[TBL] [Abstract][Full Text] [Related]
11. De novo malignancy in organ transplant recipients in Taiwan: a nationwide cohort population study.
Tsai HI; Lee CW; Kuo CF; See LC; Liu FC; Chiou MJ; Yu HP
Oncotarget; 2017 May; 8(22):36685-36695. PubMed ID: 27821818
[TBL] [Abstract][Full Text] [Related]
12. Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States.
Garrett GL; Blanc PD; Boscardin J; Lloyd AA; Ahmed RL; Anthony T; Bibee K; Breithaupt A; Cannon J; Chen A; Cheng JY; Chiesa-Fuxench Z; Colegio OR; Curiel-Lewandrowski C; Del Guzzo CA; Disse M; Dowd M; Eilers R; Ortiz AE; Morris C; Golden SK; Graves MS; Griffin JR; Hopkins RS; Huang CC; Bae GH; Jambusaria A; Jennings TA; Jiang SI; Karia PS; Khetarpal S; Kim C; Klintmalm G; Konicke K; Koyfman SA; Lam C; Lee P; Leitenberger JJ; Loh T; Lowenstein S; Madankumar R; Moreau JF; Nijhawan RI; Ochoa S; Olasz EB; Otchere E; Otley C; Oulton J; Patel PH; Patel VA; Prabhu AV; Pugliano-Mauro M; Schmults CD; Schram S; Shih AF; Shin T; Soon S; Soriano T; Srivastava D; Stein JA; Sternhell-Blackwell K; Taylor S; Vidimos A; Wu P; Zajdel N; Zelac D; Arron ST
JAMA Dermatol; 2017 Mar; 153(3):296-303. PubMed ID: 28097368
[TBL] [Abstract][Full Text] [Related]
13. Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark.
Jensen AO; Svaerke C; Farkas D; Pedersen L; Kragballe K; Sørensen HT
Acta Derm Venereol; 2010 Sep; 90(5):474-9. PubMed ID: 20814621
[TBL] [Abstract][Full Text] [Related]
14. Trends in the use of maintenance immunosuppressive drugs among liver transplant recipients in Taiwan: a nationwide population-based study.
Huang YY; Hsu CC; Chou CL; Loong CC; Wu MS; Chou YC
Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):661-7. PubMed ID: 26799240
[TBL] [Abstract][Full Text] [Related]
15. Incidence, risk factors, and preventative management of skin cancers in organ transplant recipients: a review of single- and multicenter retrospective studies from 2006 to 2010.
Mudigonda T; Levender MM; O'Neill JL; West CE; Pearce DJ; Feldman SR
Dermatol Surg; 2013 Mar; 39(3 Pt 1):345-64. PubMed ID: 23190408
[TBL] [Abstract][Full Text] [Related]
16. Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients?
Gjersvik P; Hansen S; Møller B; Leivestad T; Geiran O; Simonsen S; Pfeffer P; Fauchald P
Transpl Int; 2000; 13 Suppl 1():S380-1. PubMed ID: 11112037
[TBL] [Abstract][Full Text] [Related]
17. The association between immunosuppression and skin cancer in solid organ transplant recipients: a control-matched cohort study of 2,852 patients.
Gibson JAG; Cordaro A; Dobbs TD; Griffiths R; Akbari A; Whitaker S; Hutchings HA; Lyons RA; Whitaker IS
Eur J Dermatol; 2021 Dec; 31(6):712-721. PubMed ID: 34427560
[TBL] [Abstract][Full Text] [Related]
18. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study.
Krynitz B; Edgren G; Lindelöf B; Baecklund E; Brattström C; Wilczek H; Smedby KE
Int J Cancer; 2013 Mar; 132(6):1429-38. PubMed ID: 22886725
[TBL] [Abstract][Full Text] [Related]
19. Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer.
Karia PS; Azzi JR; Heher EC; Hills VM; Schmults CD
JAMA Dermatol; 2016 May; 152(5):533-40. PubMed ID: 26792250
[TBL] [Abstract][Full Text] [Related]
20. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients.
De Rosa N; Paddon VL; Liu Z; Glanville AR; Parsi K
JAMA Dermatol; 2019 Jun; 155(6):716-719. PubMed ID: 30865218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
